Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Februar 2019 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Present at the BIO CEO & Investor Conference

SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
30. Januar 2019 16:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study

Collaboration to advance neuropilin-2 biology and explore potential therapeutic opportunities for ATYR1923 Reinforces aTyr’s commitment to working with a strategic network of leading academic...
16. Januar 2019 16:00 ET | Quelle: aTyr Pharma, Inc.

Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease

Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work Significant opportunity to replicate collaborative model to...
02. Januar 2019 19:37 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Participation at Upcoming San Francisco Investor Events

SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
04. Dezember 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR)

SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
28. November 2018 20:16 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Present at the BMO 2018 Prescriptions for Success Healthcare Conference

SAN DIEGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
13. November 2018 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update

- Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis Planned for Fourth Quarter of 2018 - - Conference Call Today at 5:00 p.m. ET / 2:00 p.m. PT – SAN DIEGO, Nov....
08. November 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 13, 2018

SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
17. Oktober 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting

SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
15. Oktober 2018 16:30 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Leadership Transition

SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...

Vorherige Seite